Citation: | Wenjia Chen, Jinlin Li, He Wang, Ying Gao, Shuangquan Xin, Jinchuan Cao, Hao Li. High-Risk People Identification and Key Risk Factor Comparison of Cardiovascular Diseases in Northern China Rural and Urban Areas[J].JOURNAL OF BEIJING INSTITUTE OF TECHNOLOGY, 2021, 30(zk): 236-246.doi:10.15918/j.jbit1004-0579.20012 |
[1] |
James S L G, Abate D, Abate K H, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017 [J]. Lancet, 2018, 392(10159): 1789−1858.
doi:10.1016/S0140-6736(18)32279-7
|
[2] |
Roth G A, Abate D, Abate K H, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 [J]. Lancet, 2018, 392(10159): 1736−1788.
doi:10.1016/S0140-6736(18)32203-7
|
[3] |
Hu Shengshou, Gao Runlin, Liu Lisheng, et al. Summary of the 2018 report on cardiovascular diseases in China [J]. Chinese Circulation Journal, 2019, 34(3): 209−220.
|
[4] |
Cho N H, Cho Y R, Park M K, et al. Effect of blood pressure on cardiovascular diseases at 10-year follow-up [J]. The American Journal of Cardiology, 2019, 123(10): 1654−1659.
doi:10.1016/j.amjcard.2019.02.026
|
[5] |
Parizadeh D, Ghahvehchian H, Asgari S, et al. The association between changes in blood pressure components and incident cardiovascular diseases [J]. Blood Pressure, 2017, 26(6): 341−349.
doi:10.1080/08037051.2017.1353882
|
[6] |
Wang Z, Chen Z, Zhang L, et al. Status of hypertension in China results from the China hypertension survey, 2012-2015 [J]. Circulation, 2018, 137(22): 2344−2356.
doi:10.1161/CIRCULATIONAHA.117.032380
|
[7] |
Rai S, Bhatnagar S. Novel lipidomic biomarkers in hyperlipidemia and cardiovascular diseases: An integrative biology analysis [J]. OMICS Journal of Integrative Biology, 2017, 21(3): 132−142.
doi:10.1089/omi.2016.0178
|
[8] |
Zhang M, Deng Q, Wang L, et al. Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: A nationally representative survey of 163641 adults [J]. International Journal of Cardiology, 2018, 267: 218−218.
doi:10.1016/j.ijcard.2018.04.100
|
[9] |
Folkersen L, Fauman E, Sabater-Lleal M, et al. Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease [J]. Plos Genetics, 2017, 13(4): 1−21.
|
[10] |
Upala S, Sanguankeo A, Jaruvongvanich V. Gallstone diseaseand the riskof cardiovascular disease: A systematic reviewand meta-analysis of observational studies [J]. Scandinavian Journal of Surgery, 2017, 106(1): 21−27.
doi:10.1177/1457496916650998
|
[11] |
Pavlovic D, Josipovic J, Pavlovic N. Vitamin D in cardiovascularand rental disease prevention [J]. Journal of Medical Biochemistry, 2013, 32(1): 11−15.
doi:10.2478/v10011-012-0034-x
|
[12] |
Abeles A M. Hyperuricemia, gout, and cardiovascular disease: An update [J]. Current Rheumatology Reports, 2015, 17(3): 495−508.
|
[13] |
Bragg F, Holmes M V, Iona A, et al. Association between diabetes and cause-specific mortality in rural and urban areas of China [J]. JAMA Journal of the American Medical Association, 2017, 317(3): 280−289.
doi:10.1001/jama.2016.19720
|
[14] |
Claas S A, Arnett D K. The role of healthy lifestyle in the primordial prevention of cardiovascular disease [J]. Current Cardiology Reports, 2016, 18(6): 1−8.
|
[15] |
Frey P, Waters D D. Tobacco smoke and cardiovascular risk: A call for continued efforts to reduce exposure [J]. Current Opinion in Cardiology, 2011, 26(5): 424−428.
doi:10.1097/HCO.0b013e328349683d
|
[16] |
Lv J, Yu C, Guo Y, et al. Adherence to healthy lifestyle and cardiovascular diseases in the Chinese population [J]. Journal of the American College of Cardiology, 2017, 69(9): 1116−1125.
doi:10.1016/j.jacc.2016.11.076
|
[17] |
Martinez-Garcia M, Salinas-Ortega M, Estrada-Arriaga I, et al. A systematic approach to analyze the social determinants of cardiovascular disease [J]. Plos One, 2018, 13(1): 1−25.
|
[18] |
Franco M, Cooper R S, Bilal U, et al. Challenges and opportunities for cardiovascular disease prevention [J]. American Journal of Medicine, 2011, 124(2): 95−102.
doi:10.1016/j.amjmed.2010.08.015
|
[19] |
Yang X, Li J, Hu D, et al. Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese population: The China-PAR project (Prediction for ASCVD Risk in China) [J]. Circulation, 2016, 134(19): 1430−1440.
doi:10.1161/CIRCULATIONAHA.116.022367
|
[20] |
Dongfeng G, Jiang H, Xiufeng D, et al. Body weight and mortality among men and women in China [J]. JAMA Journal of the American Medical Association, 2006, 295(7): 776−783.
doi:10.1001/jama.295.7.776
|
[21] |
Liu F, Li J, Chen J, et al. Predicting lifetime risk for developing atherosclerotic cardiovascular disease in Chinese population: The China-PAR project [J]. Science Bulletin, 2018, 63(12): 779−787.
doi:10.1016/j.scib.2018.05.020
|
[22] |
Huang M, Liu S. Ending the epidemics of cardiovascular diseases: Time is now to integrate both population and individual strategies for prevention [J]. Science Bulletin, 2018, 63(12): 735−736.
doi:10.1016/j.scib.2018.05.031
|
[23] |
Anonymous. The joint task force for guideline on the assessment and management of cardiovascular risk in China [J]. Chinese Circulation Journal, 2019, 34(1): 4−28.
|
[24] |
Harris D E, Hamel L, Aboueissa A M, et al. A cardiovascular disease risk factor screening program designed to reach rural residents of Maine, USA [J]. Rural and Remote Health, 2011, 11(3): 1−15.
|
[25] |
Nuotio J, Vahamurto L, Pahkala K, et al. CVD risk factors and surrogate markers-Urban-rural differences[J]. Scandinavian Journal of Public Health, 2019. [published online ahead of print, 2019-08-29]. doi:
10.1177/1403494819869816.
|
[26] |
Yang M, Lu J, Hao Q, et al. Does residing in urban or rural areas affect the incidence of polypharmacy among older adults in western China? [J]. Archives of Gerontology and Geriatrics, 2015, 60(2): 322−333.
doi:10.1016/j.archger.2014.11.003
|
[27] |
Trivedi T, Liu J, Probst J C, et al. The metabolic syndrome: Are rural residents at increased risk? [J]. Journal of Rural Health, 2013, 29(2): 188−197.
doi:10.1111/j.1748-0361.2012.00422.x
|
[28] |
Li W, Song F, Wang X, et al. Prevalence of metabolic syndrome among middle-aged and elderly adults in China: Current status and temporal trends [J]. Annals of Medicine, 2018, 50(4): 345−353.
doi:10.1080/07853890.2018.1464202
|
[29] |
Murphy G K, McAlister F A, Weir D L, et al. Cardiovascular medication utilization and adherence among adults living in rural and urban areas: A systematic review and meta-analysis [J]. BMC Public Health, 2014, 14: 544.
doi:10.1186/1471-2458-14-544
|
[30] |
Murphy G K, McAlister F A, Eurich D T. Cardiovascular medication utilization and adherence among heart failure patients in rural and urban areas: A retrospective cohort study [J]. Canadian Journal of Cardiology, 2015, 31(3): 341−347.
doi:10.1016/j.cjca.2014.11.024
|
[31] |
Kario K, Kanegae H, Tomitani N, et al. Nighttime blood pressure measured by home blood pressure monitoring as an independent predictor of cardiovascular events in general practice [J]. Hypertension, 2019, 73(6): 1240−1248.
doi:10.1161/HYPERTENSIONAHA.118.12740
|
[32] |
Griswold M G, Fullman N, Hawley C, et al. Alcohol use and burden for 195 countries and territories, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016 [J]. Lancet, 2018, 392(10152): 1015−1035.
doi:10.1016/S0140-6736(18)31310-2
|
[33] |
Degenhardt L, Charlson F, Ferrari A, et al. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016 [J]. Lancet Psychiatry, 2018, 5(12): 987−1012.
doi:10.1016/S2215-0366(18)30337-7
|